Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer

Immune checkpoint inhibitors (ICIs) are new therapeutic strategies for non-small cell lung cancer (NSCLC). We aimed to quantitatively evaluate the efficacy and safety of ICIs in NSCLC. Pubmed, Embase, Cochrane Library, and Web of Science were searched for randomized clinical trials comparing ICIs wi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncoimmunology
Main Authors: Wang, Shuai, Hao, Jiatao, Wang, Hao, Fang, Yong, Tan, Lijie
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2018
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136858/
https://ncbi.nlm.nih.gov/pubmed/30221052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1457600
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍